The startup company AliveCor has unveiled its new Kardia Electrocardiogram (ECG) Band for the Apple Watch on Wednesday, pending its FDA approval. The new device is designed in order to bring users a sophisticated piece of technology able to warn them of their heart conditions at all times.
The Kardia ECG Band can indicate the wearer’s cardiac arrhythmia conditions capable of causing a stroke as well as serving as an indicator of heart rate and blood oxygenation. The latest version of the startup company AliveCor also intends to help users get tested in many physical condition aspects in order for them to keep better track of their health routine.
Along with the Kardia Apple Watch app, the Kardia ECG Band also integrates with Apple’s Health platform, allowing the band to record other health factors such as caloric intake, blood pressure and exercise. There’s no wonder that the medical technology company AliveCor poses a threat for the app designers that claim to develop ‘fitness apps’ yet lack the technology to back up their work.
The new device developed by AliveCor contains not only an integrated sensor but also can communicate with the Kardia’s app, according to Tech Crunch. This may not sound as much, but considering that Kardia’s app runs the data compiled through the integrated sensor through an analysis algorithm capable of detecting abnormal heartbeats, which are the common indicator of a stroke.
Wearable medical technology
In addition to preventing possible strokes in users, the analysis made by the app from AliveCor’s Kardia ECG Band can be e-mailed directly to a doctor in case of emergency. This would not only help users to better respond in the sudden case of a stroke, but would also provide rescue for a patient suffering a stroke as it would indicate it ahead of time.
Plus, users can even record a voice note describing their symptoms and attach it to the analysis before sending it to a physician for review. Notably, this would allow doctors to better diagnose their patients due to the effectiveness of the data transmission from the Kardia’s app to the doctor and the possibility for the user to describe the symptoms in real time.
“Kardia Band for Apple Watch represents both the future of proactive heart health and the introduction of the Wearable MedTech category,” said Vic Gundotra, Chief Executive Officer at AliveCor.
It’s worth noticing that the FDA already approved Kardia with its previous version for smartphones called Kardia Mobile, AliveCor is awaiting clearance from the FDA’s administration that is expected to approve the ECG Band in spring this year.